Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzutifan in Advanced ccRCC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Michael Atkins
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Michael Atkins
95 views
June 10, 2024
Chapters
Belzutifan & Advanced Renal Cell Carcinoma
00:00
LITESPARK-013 Study Design & Demographics
01:56
Subgroup Efficacy Analysis Results
04:03
Conclusions & Future Research Directions
08:47
Comments 0
Login to view comments.
Click here to Login